Hypoglycemic peptide-enriched hydrolysates of Corbicula fluminea and Chlorella sorokiniana possess synergistic hypoglycemic activity through inhibiting α-glucosidase and dipeptidyl peptidase-4 activity

BACKGROUND The prevalence of diabetes mellitus worldwide has increased in recent decades. Maintaining the level of blood glucose is the most basic and important issue for diabetics. This study aimed to investigate the hypoglycemic activity of a combination of hypoglycemic peptide-enriched hydrolysates of Corbicula fluminea (ACH) and Chlorella sorokiniana (PCH). RESULTS Combined supplementation of ACH and PCH synergistically inhibited alpha-glucosidase and DPP4 activities in vitro. After 4 weeks of treatment with ACH and/or PCH, the plasma glucose concentration and insulin, homeostasis model assessment-estimated insulin resistance (HOMA-IR), total cholesterol (TC) and triglyceride (TG) levels significantly decreased. The hypoglycemic peptides in ACH and PCH were purified and assayed for alpha-glucosidase and DPP4 activity. The hypoglycemic peptides in ACH and PCH effectively decreased alpha-glucosidase and DPP4 activities. In silico assays showed that these two peptide types have different docking poses, which determined their inhibitory effect against alpha-glucosidase and DPP4 activity. CONCLUSION Combined treatment with hypoglycemic peptide-enriched ACH and PCH could modulate blood glucose by synergistically inhibiting alpha-glucosidase and DPP4 activities. (c) 2021 Society of Chemical Industry.

Automated summary

The prevalence of diabetes worldwide has been increasing in recent decades. This study focused on investigating the hypoglycemic activity of a combination of hypoglycemic peptide-enriched hydrolysates of Corbicula fluminea (ACH) and Chlorella sorokiniana (PCH). The results showed that combined supplementation of ACH and PCH could synergistically inhibit alpha-glucosidase and DPP4 activities, leading to a decrease in blood glucose levels and insulin resistance.